Tarsus Pharmaceuticals Inc (TARS)
49.22
+2.72
(+5.85%)
USD |
NASDAQ |
Nov 14, 10:35
Tarsus Pharmaceuticals Price to Book Value: 7.423 for Nov. 14, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 13, 2024 | 7.013 |
| November 12, 2024 | 7.174 |
| November 11, 2024 | 7.402 |
| November 08, 2024 | 7.453 |
| November 07, 2024 | 7.056 |
| November 06, 2024 | 7.058 |
| November 05, 2024 | 6.886 |
| November 04, 2024 | 6.969 |
| November 01, 2024 | 7.133 |
| October 31, 2024 | 6.710 |
| October 30, 2024 | 6.746 |
| October 29, 2024 | 6.616 |
| October 28, 2024 | 5.983 |
| October 25, 2024 | 5.944 |
| October 24, 2024 | 5.865 |
| October 23, 2024 | 5.882 |
| October 22, 2024 | 5.731 |
| October 21, 2024 | 5.497 |
| October 18, 2024 | 5.523 |
| October 17, 2024 | 5.591 |
| October 16, 2024 | 5.669 |
| October 15, 2024 | 5.622 |
| October 14, 2024 | 5.502 |
| October 11, 2024 | 5.386 |
| October 10, 2024 | 5.354 |
| Date | Value |
|---|---|
| October 09, 2024 | 5.238 |
| October 08, 2024 | 5.128 |
| October 07, 2024 | 5.008 |
| October 04, 2024 | 5.111 |
| October 03, 2024 | 4.867 |
| October 02, 2024 | 4.939 |
| October 01, 2024 | 4.870 |
| September 30, 2024 | 4.960 |
| September 27, 2024 | 4.903 |
| September 26, 2024 | 4.999 |
| September 25, 2024 | 4.883 |
| September 24, 2024 | 4.981 |
| September 23, 2024 | 5.004 |
| September 20, 2024 | 5.204 |
| September 19, 2024 | 5.218 |
| September 18, 2024 | 4.909 |
| September 17, 2024 | 4.683 |
| September 16, 2024 | 4.808 |
| September 13, 2024 | 5.016 |
| September 12, 2024 | 4.781 |
| September 11, 2024 | 4.796 |
| September 10, 2024 | 4.742 |
| September 09, 2024 | 4.713 |
| September 06, 2024 | 4.613 |
| September 05, 2024 | 4.119 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.652
Minimum
Mar 24 2023
7.453
Maximum
Nov 08 2024
3.251
Average
2.861
Median
Jun 16 2023
Price to Book Value Benchmarks
| Amicus Therapeutics Inc | 17.14 |
| CEL-SCI Corp | 4.283 |
| AIM ImmunoTech Inc | 2.583 |
| IGC Pharma Inc | 3.484 |
| NovaBay Pharmaceuticals Inc | -- |
Price to Book Value Related Metrics
| PS Ratio | 20.23 |
| PEG Ratio | -0.3394 |
| Price | 49.22 |
| Earnings Yield | -9.10% |
| Market Cap | 1.872B |
| PEGY Ratio | -0.3394 |